Synergy Pharmaceuticals Inc. (SGYP) Stock Down After Price Target Increase at Rodman & Renshaw

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) shares were down on Friday January 20 on heavier trade volume than normal after a number of analysts weighed in on the investing value of the stock, increasing the price target of stock.

Meanwhile, U.S. stocks rose Friday morning as Wall Street closely awaited Donald Trump’s inauguration as the nation’s 45th president.

The Dow Jones Industrial Average DJIA, +0.41% rose 95 points, or 0.5%, to 19,826, while the S&P 500 index SPX, +0.41% climbed 11 points, or 0.5%, to 2,275 and the Nasdaq Composite COMP, +0.37% added 28 points, or 0.6%, to 5,571.

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) had its price target increased by equities researchers at Rodman & Renshaw from $17.00 to $18.00. The company currently has a rating of Buy on the stock. The one-year price target of $10.67 is higher than the opening price of $6.57, causing a number of other analysts to report on the company in recent days. Looking back over the last year, Synergy Pharmaceuticals Inc. stock has a high of $6.97.

Shares of Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) opened at $6.57 yesterday and traded in a range between, $6.10 and $6.71, and last traded at $6.16, a dip of $0.26 from the previous closing price.

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) currently has a market cap of 1.11B.

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) Average Daily Trading Volume

The stock’s average daily volume is 4,462,150 shares out of a total float 147,990,000 and some 6,261,691 shares crossed the trading desk yesterday, 51 percent above the average. higher than normal. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts that research thousands of stocks, so it is good corroboration to see them buying a stock you’re researching.

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

Trades for Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) have ranged from $2.50 – 6.970, and the stock now has a 50-day MA of $5.78 and 200-day MA of $5.10. Today’s last price is 11.69%% under the 52 week high of $6.97.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors look for companies that have been successful at growing their earnings by at least 25% for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply